To coincide with the publication of EFPIA’s annual “Pipeline Review”, EFPIA held a high-level panel discussion around the latest medical research outcomes, joined by representatives from patient organisations, EU institutions, and industry. Read more: https://efpia.eu/news-events/the-efpi...
The International Quality Network for Pathology (IQN Path), the European Cancer Patient Coalition (ECPC) and the European Federation of Pharmaceutical Industries and Associations (EFPIA) jointly share the findings from the study “Unlocking the potential of precision medicine in Europe – Improving cancer care through broader access to quality biomarker testing”.
The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.